To confirm this assumption, we measured the overall levels of O-GlcNAcylation in tumor tissues and found that tumor tissues with high expression of GFPT2 tended to have high overall levels of O-GlcNAcylation (Fig. 4A). The gene discussed is GFPT2; the disease is neoplasm.